MajesTEC-4

Phase 3 Study of Teclistamab in Combination With Lenalidomide and Teclistamab Alone Versus Lenalidomide Alone in Participants With Newly Diagnosed Multiple Myeloma as Maintenance Therapy Following Autologous Stem Cell Transplantation - MajesTEC-4

Near Add Your Location

Sorting 40 by

University of Colorado Cancer Center
Anschutz Cancer Pavilion
Aurora, CO
  • Not yet accepting
University of Wisconsin - Carbone Cancer Center
University of Wisconsin Health
Madison, WI
  • Accepting patients
Vanderbilt-Ingram Cancer Center
Henry-Joyce Cancer Clinic
Nashville, TN
  • Accepting patients
University of Cincinnati College of Medicine
George L. Strike Bone Marrow Transplant Program
Cincinnati, OH
  • Accepting patients
University of Maryland Medical Center
Marlene and Stewart Greenebaum Comprehensive Cancer Center
Baltimore, MD
  • Accepting patients
Gibbs Cancer Center and Research
Spartanburg Medical Center
Spartanburg, SC
  • Not yet accepting
Virginia Oncology Associates
Newport News, VA
  • Accepting patients
Virginia Oncology Associates - Lake Wright
Norfolk (Lake Wright)
Norfolk, VA
  • Accepting patients
Moores Cancer Center
University of California UC San Diego Health
La Jolla, CA
  • Accepting patients

Real People. Real Support.

Need help connecting with this clinical trial? We're here to help!

Print Report

Print a patient-friendly report to share with your patient.

(888) 850-0650

We can help answer any questions and connect you (or your patient) with the study team.

Schedule Call

Schedule a time that is convenient and we’ll call you to see how we can help you and your patient.